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PSYCHOIMMUNOLOGY AND FUNCTIONAL 
PSYCHOSES: THE INDIAN SCENE 
S.C.TIWARI 
TILAK VENKOBA RAO ORATION 
Mr. Chairperson, co-chairperson, my teachers 
sitting in this august audience, members of our 
society, distinguished guests, ladies and gentlemen: 
This morning in beautiful city of Lucknow, I have 
been selected to deliver the "Tilak Venkoba Rao 
oration" which is indeed a land mark step in my 
career for a variety of reasons. I am fortunate that I 
am delivering this oration in the city of my alma 
mater where I have grown worthy of this oration. I 
owe a lot to my alma mater and to my revered 
teachers particularly Prof. B.B. Sethi who brought 
about a revolution in biological psychiatric research 
at Lucknow center. I have never met Tilak but as 
much as I know about him, he was a worthy son of 
worthy parents Prof. Venkoba Rao and Dr.(Smt.) 
Parvathi Devi. I pay my regards to 'Tilak and I am 
sure that the institution of this award after his name 
will always encourage behaviorists to research 
newer areas in the field of biological psychiatry. 
Before I deliberate upon the main body of oration, I 
must thank my parents and my parents-in-law who 
are also sitting in audience for this prestigious day 
of my career without whose blessings this achieve-
ment could not have been possible. Lastly, I must 
thank my wife Smt. Shweta Tiwari who is also 
present here and whose love and constant en-
couragement and sacrifice has enabled me to see the 
dawn of this momentous day in my life. 
BACKGROUND 
My interest in psychoimmunological studies was 
triggered off by my first research work on the viral 
hypothesis of functional psychoses, which was prin-
cipally an immunological study and also because of 
curiosity to observe etiological correlates of mental 
disorders in the laboratory test-tube. 
The term 'immunopsychiatry' (or psychoim-
munology) was introduced by Jankovic to denote the 
involvement of immune processes, both humoral 
and cell mediated, in the pathogenesis of certain 
mental disorders. The term did not appear de novo, 
but because of certain important observations which 
made it imperative: 
a) in vivo effects of antibrain antibodies on the 
bioelectrical activity of brain structures and be-
havior (Mihailovic & Jankovic, 1961); 
b) the speculation that schizophrenia is an im-
munological disorder (Health & Krupp, 1967); 
c) the modulation of learning and memory by 
means of antibrain antibodies (Jankovic, 1985); 
d) alterations in immune status following viral 
infections and the proposed viral hypothesis of 
schizophrenia (Torrey et al, 1978); 
e) the correlation between cerebral atrophy of 
unknown origin and cell mediated immunity 
(Jankovic et al, 1977). 
The first three experimental and clinical studies 
have dealt with the activity of antibrain antibodies 
(e.e. humoral immunity), the fourth with both 
humoral and cellular immunity, whereas the last one 
relates to the role of cellular immunity in the 
pathogenesis of psychiatric disorders (Jankovic, 
1985). These findings provided the much needed 
theoretical basis for imm unologic research in mental 
disorders. Though inconclusive, these investigations 
have been instrumental in at least heralding a new 
era of scientific inquiry into the hitherto unknown 
etiopathogenesis of mental disorders. 
The development of immunological research in 
psychiatry has an uneven history. A preliminary 
outline of the immune system's capability to resist 
infections was delineated by the end of the 19th 
century. However, investigations of the relationship 
between the central nervous and immune systems 
began after almost three decades with Sir Thomas 
Lewis' study of the "Triple Response" in !920. This 
was followed in the next two decades by 
Speransky's (Pavlov's colleague) conditioning 
studies exhibiting the effect of the CNS on im-
munopathologic phenomena and by Selye's descrip-
tion of the CNS - pituitary - adrenal axis effects on 
the immune function at many levels. 
This initial period of enthusiasm was followed by 
a major swing away from the study of the nervous 
system's possible influence on the immune system, 
because of the then gathering evidence that the im-
mune system can function independently and 
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autonomously, and this negative phase lasted for a 
quarter century or so (Waksman, 1985). However, 
with subsequent developments in molecular biology 
and immunology, both in terms of understanding 
and methodological innovations, a large body of 
experimental evidence has gathered during the last 
two decades which points towards the existence of 
complex interactions between the nervous and the 
immune systems (Felten et al, 1985). With this 
knowledge, psychoimmunology has not looked 
back; since then the development of immunological 
research in psychiatry has run parallel to that of 
immunology, reflecting methodological and 
theoretical advances made in the latter field. 
RESEARCH STRATEGIES 
Immune alterations manifest either into overac-
tive or into underactive immune responses. If the 
source of immunogen is endogenous, the resultant 
immune disorder is autoimmunity in the case of an 
overactive immune response, and malignancy in the 
case of an underactive response. If the source of 
immunogen is exogenous, the resultant im-
munological disorder is an allergy in case of overac-
tive immune response and infection in the case of an 
underactive immune response. Investigative 
strategies in psychoimmunology have progressed 
along these four lines. The majority of research in 
psychoimmunology commenced in the 1960's, 
though evidence of a dysfunctional immunological 
system in psychiatric disorders were already present 
since the early l
lXX)'s. Both immune overactivity 
and underactivity have been extensively inves-
tigated. The I "70'sand 1980's have seen revitalized 
activities in this area with the appearance of new 
centers in which involvement of the immune system 
in endogenous psychoses has been extensively ex-
amined. 
A number of centers across the globe are examin-
ing these matters, but the contributions and coor-
dinaiing activities of the W.H.O. in promoting 
immunological research in psychiatry deserves spe-
cial mention, 'lhe division of mental health of the 
W.H.O. has. since 1078, organized one or two sym-
posia each year as part of the World Congress of 
Biological Psychiatry, at which results of research 
in this field ;ire discussed. A program entitled 'An-
tithymic AntiNxlics in Schizophrenia', involving 
seven research centers, tixik place between 1973 and 
1978 under lhe aegis of lhe W.H.O. The results of 
this program are set out in a joint publication and 
have served as the basis for further development of 
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immunological studies at a number of centers (Kol-
zaskina et al, 1980). In recent years, two conferences 
devoted entirely to 'Viruses, Immunity and Mental 
Disorders' were organized with the help of the 
W.H.O. (Louvain, Belgium, 1983; Montreal, 
Canada, 1984), and the results have been published 
in two monographs (Morozov, 1983; Kurstak et al, 
1987). 
In the assessment of over and underactive im-
mune responses, both humoral and cell mediated 
immunological parameters have been investigated. 
In addition, other biological parameters which arc 
thought to be linked with the immune system, such 
as hormones, neurotransmitters, enzymes, etc., have 
also been investigated. There is an exhaustive list of 
such investigations, but they have mainly been car-
ried out in Western countries. This reflects the ac-
cessibility to resources, methodological and 
technological advancements etc. In India, these is-
sues have played a detrimental role in research 
development in almost every field of medical 
science including psychoimmunology. Isolated 
studies are available from a few centers and the 
majority of work in this area has been carried out by 
us at Lucknow. Only functional psychoses have 
been investigated in India, though other mental dis-
orders such as stress related disorders, drug addic-
tions, etc. have been investigated elsewhere in the 
world. What follows is the narration of our activities 
and future plans in this field. 
PSYCHOIMMUNOLOGICAL RESEARCH: 
THE INDIAN SCENE 
Contribution of Lucknow center: 
The very first study in this area in India was 
carried out at Lucknow center and it reported that all 
cases of schizophrenia studied had atypical lym-
phocytes (Sethi & Sethi, 1971). The study did not 
attempt to differentiate between T and B lym-
phocytes, nor were their functional aspects inves-
tigated. Perhaps, the study was not planned from an 
immunological perspective. 
The second study in the country was also carried 
outat Lucknow center in 1976-77 by Dr.R.S. Pandey 
and colleagues. This work had the autoimmune 
hypothesis in the background and overactive im-
mune response was investigated in schizophrenic 
subjects employing antigens specifically prepared 
from different area of brain tissue. A total of 54 
schizophrenic and 27 non-schizophrenic medical 
patients were studied. Antigens were prepared from 
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and parts of the extrapyramidal system from a 35 
year old man who had died 2 hours after an 
automobile accident. Antibodies against these an-
tigens (antibrain antibodies) were studied in the 
serum and CSF of experimental and control subiects. 
It was found that antibrain antibodies were 
present in the serum and CSF of 48.1% of the 
schizophrenic patients and in none of the control 
subjects, with high titres of antibrain antibodies 
being present only in serum. There was no sig-
nificant difference in the antigenicity of the three 
antigens. Further, it was found that antibodies were 
more commonly found in serum and CSF of those 
schizophrenics who had a longer duration of illness, 
more episodes, positive family history for 
schizophrenia, and who received the diagnosis of 
chronic undifferentiated schizophrenia (Pandey et 
al. 1981). The study results favored the autoimmune 
hypothesis for schizophrenia. There is no other 
report of this nature from the Indian subcontinent. 
There is an enormous amount of literature on this 
issue from western countries, but till date the status 
of the autoimmune hypothesis remains controversial 
(Ganguly et al, 1987; Koljaskina & Prilipko, 1988). 
Psyche-immunology became the area of my inter-
est in the late 1970's when the viral hypothesis of 
functional psychoses was regaining ground (Torrey 
et al, 1978). The first study which 1 planned was on 
immunoglobulins and viral antibodies in 
schizophrenic and depressive patients (Tiwari, 
1982). This, my maiden attempt, explored the pos-
sibility of an underactive immune response in func-
tional psychoses. I had two objectives in mind, the 
first being to study the pattern of immunoglobulins 
and anti-viral antibodies in the serum and CSF of 
schizophrenic and depressive patients, and the 
second being to study the relationship between ill-
ness variables and immunological parameters. 
The sample for the study comprised of 30 
schizophrenics, 30 depressives, 20 controls (non-
psychiatric, non-neurological surgical patients 
scheduled to be operated under spinal anaesthesia), 
and, in addition, 20 neurological controls of either 
unknown, multiple, or doubtful etiology. All 
patients and controls were recruited following strin-
gent inclusion and exclusion criteria. Total CSF 
protein, humoral immunoglobulins G, A and M an-
tibodies against rubella (hemagglutination inhibi-
tion antibodies) and against cytomegalovirus 
(complement fixing antibodies) in the serum and 
CSF of all subjects were investigated. Part of the 
results have been published (Tiwari etal, 1984,1969 
& 1990). Essentially, it was a negative study and the 
results were neither in favor of an underactive im-
mune response, nor in favor of the viral hypothesis 
of schizophrenia and depression. Instead, part of the 
results favored an overactive immune response and 
thus provided some supportive evidence for the 
autoimmune hypothesis. Nonetheless, some of the 
observations deserve special mention. 
Of the depressives in this study, 33.7% had raised 
total CSF proteins - a pattern also noticed in 
neurological patients. Serum IgG was significantly 
higher in depressives and in neurological controls, 
whereas serum IgA was significantly higher in 
schizophrenia, depression and neurological con-
trols. IgM was within normal limits. In the CSF, IgG 
was detected in all subjects, and was significantly 
higher in schizophrenics, depressives and neurologi-
cal subjects, whereas IgA was detected in the CSF 
of only 23% depressives and 25% neurological 
patients and IgM was detected only 25% of 
neurological patients. 
The hemagglutination inhibition (HI) antibodies 
against rubella virus, tested in the lowest and highest 
dilutions of 1:20 and 1:1280 respectively, were 
found in the serum of all the subjects and the in-
cidence of seropositive cases and the geometric 
mean of antibody titres were found to be higher (but 
not statistically significant) in schizophrenic, 
depressive and neurological subjects as compared to 
surgical controls. HI antibodies were not detected in 
the CSF of any of the subjects. The complement 
fixing (CF) antibodies against cytomegalovirus, 
tested in lowest and highest dilutions of 1:8 and 
1:256 respectively, were found to have a pattern 
similar to HI antibodies and these two were not 
detected in the CSF of any of the subjects. The 
immunoglobulin levels were found to be significant-
ly higher in the serum of schizophrenics and depres-
sives and had a direct relationship with the total 
duration (longer duration) of illness, number of 
episodes (more episodes) and positive family his-
tory. 
When an infectious agent, such as a virus, is 
suspected to be the cause of a particular diseased 
state, the immune response is usually expected to be 
hypoactive. However, in this study, an almost op-
posite trend was noticed, thus apparently refuting the 
viral hypothesis of schizophrenia and depression. 
However, it is known that certain viruses in certain 
circumstances trigger an autoimmune response 
either by affecting the B lymphocyte or the T lym-
phocyte regulatory function. Do, then, the increased 
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immunoglobulins in this study indicate the presence 
of viral infections? As anti-viral antibodies were not 
detected and T cells were not investigated in thk> 
study, no conclusions can be drawn. Do these obser-
vations, then, favor the autoimmune hypothesis? For 
an autoimmune disease, there should be, besides 
elevated immunoglobulins, presence of various 
auto-antibodies, depressed levels of serum comple-
ment, immune complexes in the serum, depressed 
levels of T suppressor cells, etc. None of these 
variables were investigated and, therefore, any in-
ference about autoimmunity will be far fetched. 
The results of the study, however, did indicate 
that depressives in many immunological aspects 
resembled neurological patients who were of either 
unknown, multiple, or doubtful etiology (Guillian-
Barre syndrome (6), motor neurone disease (4), 
idiopathic epilepsy (5), cerebellar ataxia (3) and 
Parkinson's disease (2) (a total of 20 patients). This 
was the most important finding of the study and 
provides enough ground for future immunological 
research. 
Our second major work in the area of psychoim-
munology was the result of our previous work and 
the unconfirmed reports in the literature that 
psychotropic drugs have an adverse effect on im-
mune function. The work in this direction was car-
ried out in 1987-88 and was entitled, 'A study of the 
effects of psychotropic drugs on humoral and cell 
mediated immune responses in schizophrenics and 
depressives'. The work was carried out by Dr. D.K. 
Agarwalla, a postgraduate psychiatry student, under 
my co-supcrvisorship and part of the results have 
been published (Agarwalla et al, 1991). Thirty sub-
jects (12 drug naive and 18 total drug free for 3 
months) each of schizophrenia and depression were 
recruited along with 15 healthy volunteers (controls) 
for the study. In al! of these subjects, quantitative 
assessment of the immune system was done by 
assaying the humoral (IgO, IgA and IgM) and cel-
lular (T and B lymphocyte) fractions in peripheral 
blood, qualitative assessment of immune function 
was done in vivo by the PHA (Phenyl hemag-
glutinin) skin test. Both the quantitative and qualita-
tive assessment was done at base line, and after 2 and 
4 weeks in schizophrenics and depressives, while it 
was done only once in controls. 
To study the effects of psychotropic drugs, 
chlorpromazine and haloperidol were administered 
to schizophrenics, and tmipramine and amitnptylinc 
were administered to depressives. The results of the 
study showed that pretreatment immune profile was 
similar in patients and controls. After 2 weeks of 
treatment, chlorpromazine did not produce any sig-
nificant change in the immunological parameters, 
but after 4 weeks there was a significant rise in 
absolute T and B cell counts, though humoral im-
munoglobulins and PHA skin test did not show any 
significant change. On the other hand, haloperidol 
invoked immunopotentiation after only 2 weeks of 
treatment as evidenced by significantly increased 
immunoglobulin G and T and B cell counts. The 
trend was maintained at the end of 4 weeks treatment 
as well. In addition, at the end of 4 weeks, there was 
a significant elevation of serum IgM levels. PHA 
skin test, however, remained unaltered. 
Both imipramine and amitriptyline were found to 
be immunopotentiating and except for serum IgG 
and PHA skin test, all other immunological 
parameters (IgA, IgM and absolute T and B cell 
counts) showed significant elevation after 2 and 4 
weeks of treatment. To test whether clinical im-
provement in patients was the result of im-
munopotentiation by psychotropic drugs, the 
improved schizophrenics and depressives were 
compared with non-improved groups and it was 
found that the immunological profile of the two 
groups did not differ. 
This study raised some important questions. Is 
immune profile unrelated to schizophrenic and 
depressive psychopathology? Is immunopotentia-
tion a non-specific phenomenon, particularly in 
terms of clinical improvement? Is immunopotentia-
tion in any way related to the course and outcome of 
schizophrenic and depressive pathology? These is-
sues remain unanswered by our study. It may be 
speculated that there is a non-specific im-
munopotentiation by psychotropic drugs used in the 
study in the initial phase of treatment which might 
return back to the preexisting state during the later 
course of therapy, or else, if the elevation persists, it 
is simply non-specific. Perhaps, a long term study 
might answer some of these questions. 
These findings indicate that neuroleptics and an-
tidepressants cause immunomodulation, more 
specifically immunopotentiation. This observation 
and reports of immunomodulation in the literature 
(Vertanian & Koljaskina, 1987) inspired us to take 
up the third work in the field of psychoimmunology 
in 1989-90. Dr. Sanjay Agarwal, another 
postgraduate student, carried out the work entitled 
'Role of an immunomodulator in the treatment of 
schizophrenics', under my co-supervisorship. It was 
based on the observation that there is a hyperrespon-
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sive B cell functioning (increased production of 
humoral immunoglobulins) in schizophrenics due to 
diminution in regulatory activity of T suppressor 
cells, secondary to a reduction in the number of T 
suppressor cells. This led to the hypothesis that by 
use of an immunomodulator, T suppressor cell 
functioning can be corrected which will eventually 
correct the hyperresponsive B cell functioning (Ver-
tanian & Koljaskina, 1987). This work of ours was 
the result of this hypothesis, and we attempted to 
study the efficacy of an immunomodulating agent, 
levamisole, using the agent as adjunct to neurolep-
tics in the treatment of schizophrenia. 
Thirty four schizophrenics, recruited following 
rigorous inclusion and exclusion criteria, underwent 
a six weeks trial in which eighteen patients (ex-
perimental group) received levamisole and 
chlorpromazine alone following randomization. 
Chlorpromazine was given in a dose of 15 mg/kg 
body weight per day for the study period, and 
levamisole in the dose of 150 mg twice a week 
throughout the study. Immunological parameters 
(IgG, IgA IgM and C3,C4 complements, T cells, B 
cells and T suppressor cells) were studied on day 0 
(baseline) and on days 21 and 42. These observa-
tions have been very encouraging. The study 
revealed that T suppressor cells are decreased in 
number in chronic schizophrenics. On treatment 
with levamisole, this decrease is corrected and the 
schizophrenics showed corresponding clinical im-
provement as well. Moreover, the coefficient of 
correlation revealed that this increase in T suppres-
sor cell number is significantly correlated with the 
improvement in the psychosis. The observations 
thus indirectly support the autoimmune hypothesis 
of schizophrenia and also provide evidence that 
chronic schizophrenics respond better to conven-
tional neuroleptics when treated in combination with 
levamisole. The only lim iting factor in the study was 
a small sample size, and there is obviously a need 
for a larger study. 
OTHER INDIAN CONTRIBUTIONS 
Only a few other workers have attempted 
psychoimmunologicai studies in schizophrenia. Rao 
and associates at N1MHANS, Bangalore, studied 
serum immunoglobulins in schizophrenics as com-
pared to controls (Rao et al, 1985). The investigators 
studied the effects of treatment and illness profile on 
immunoglobulins. It was a negative study and no 
association / correlation could be established. A 
similar work has been carried out at the Department 
of Psychiatry, Institute of Medical Sciences, BHU, 
Varanasi, under the supervisorship of Dr. I. Sharma 
(personal communication). The results are yet to be 
published. I am not aware of any other work in this 
field by any other center in the country. 
CURRENT ACTIVITIES AT LUCKNOW CENTER 
AND FUTURE DIRECTIONS 
Another study which has been planned is about 
the genetic aspects of psychoimmunology. 
Schizophrenic and depressive probands with family 
history of illness in their first degree relatives are to 
be investigated. In particular, T suppressor cells are 
to be studied which have almost conclusively been 
shown to play a role in autoimmune diseases. 
Till date, inspite of concerted and sincere efforts, 
no definite direction could be delineated, except that 
in our most recent work, we could detect decreased 
T suppressor cell numbers. This observation and 
findings of increased levels of immunoglobulin does 
indicate the possibility of an autoimmune aetiology 
of schizophrenia. Further, in our first study, we 
found similarities between depressives, 
schizophrenics, and neurological controls of un-
known, doubtful or of multiple etiology, particularly 
with Guillian-Barre syndrome for which a viral 
etiology is proposed. With these findings we stand 
at a crossroad, and are eager to pursue both roads, 
i.e. that of autoimmunity and of a viral hypothesis. 
No doubt, the future of psychoimmunology is 
promising and several avenues are open for further 
research. Besides autoimmunity and infection 
(viral?), the other roads which could be travelled are 
that of immunogenetics and allergic / hypersen-
sitivity reactions in the understanding of the com-
plex aetiopathology of functional psychoses. 
Internationally, this area is being pursued vigorously 
and all aspects of immune function including 
genetic, biochemical, endocrinal etc., are being in-
vestigated. India is rich with fresh and untreated 
patient populations with adequate climatic varia-
tions and, therefore, the country should provide the 
most fertile ground for psychoimmunologicai re-
search. 
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